Johnson & Johnson Private Limited
Clinical trials sponsored by Johnson & Johnson Private Limited, explained in plain language.
-
New drug teclistamab tested for Tough-to-Treat blood cancer in india
Disease control Recruiting nowThis study is testing the safety of a drug called teclistamab in Indian adults with multiple myeloma, a blood cancer that has come back or stopped responding to treatment. Participants must have already tried at least three different types of therapy. The goal is to see how safe …
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated May 17, 2026 03:41 UTC
-
New hope for psoriatic arthritis patients: guselkumab study launches in india
Disease control Recruiting nowThis study tests the safety and effectiveness of guselkumab, a biologic drug, in 100 Indian adults with active psoriatic arthritis who did not get enough relief from standard treatments. Participants receive injections and are monitored for side effects and joint symptom improvem…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated May 17, 2026 03:38 UTC